Xydalba (dalbavancin)

pCPA File Number: 22085
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute bacterial skin and skin structure infections
Sponsor/Manufacturer:
Paladin Labs Inc.
CDA-AMC Project Number:
SR0728-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: